|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 20 F STREET NW |
Address2 | SUITE 1000 |
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 91251-12
|
||||||||
|
6. House ID# 363620000
|
TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Christian Shalgian |
Date | 4/16/2020 1:14:47 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
PL 109-417 - Pandemic and All-Hazards Preparedness Act (PAHPA)
PL 116-127/H.R. 6201 - Families First Coronavirus Response Act
H.R. 6365/S. 3559 - The Immediate Relief for Rural Facilities and Providers Act
H.R. 748/S. 3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act
S. 1895 - Lower Health Care Costs Act
H.R. 5800 - Ban Surprise Billing Act
H.R. 5826 - Consumer Protections Against Surprise Medical Bills Act
H.R. 3630 - No Surprises Act
H. R. 8 - Bipartisan Background Checks Act of 2019
H. R. 1418 - Competitive Health Insurance Reform Act of 2019
S. 668/H.R. 1570 - Removing Barriers to Colorectal Cancer Screening Act of 2019
S. 966 - Medicare Care Coordination Improvement Act of 2019
S. 2372 - VA MISSION Act of 2018
S. 741/H. R. 1730 - Cancer Drug Parity Act of 2019
H. R. 1379 - Ensuring Lasting Smiles Act
H. R. 207 - Stop the Violence Act of 2019
H. R. 1841 - Ensuring Access to General Surgery Act of 2019 (and Senate version reintroduction)
H. R. 1041 - Critical Access Hospital Relief Act of 2019
H.R. 3656/S. 1350 - ACCESS Act of 2019
H.R. 861 End Surprise Billing Act
H.R. 3630 No Surprises Act
H.R. 3502 Protecting People from Surprise Medical Bills Act
H.R. 2550 - Prevent BLEEDing Act of 2019
H. R. 2143 - Promoting Integrity in Medicare Act of 2019
H. R. 3107 - Improving Seniors' Timely Access to Care Act of 2019
H. R. 1332 - Fair Care Act of 2019
H.R. 2464 - End the Cycle of Violence Act of 2019
S. 1895 Lower Health Care Costs Act
S. 967 Reducing Costs for Out of Network Services Act
S. 1266 Protecting Patients from Surprise Medical Bills Act
S. 1531 Stopping the Outrageous Practice of Surprise Bills Act
S. 1607 Medical Billing Fairness Act
H. R. 1763/S. 348 - Resident's Physician Shortage Reduction Act
S. 1350 - Good Samaritan Health Professionals Act
H. R. 2689/S. 1438 - Breast Cancer Research Stamp reauthorization
H.R. 4350/S. 3085 - Ambulatory Surgical Center Quality and Access Act of 2019
Cures 2.0
E/M Global Code Issues
Unique Patient Identifier
Lower Health Care Costs Act Compromise
Bleeding Control for the Injured (Stop The Bleed campaign)
Qualified clinical data registry (QCDR)
Firearms Safety and Research
MACRA Implementation
Merit-based Incentive Payment Systems (MIPS)
Alternative Payment Models (APM)
Outpatient Prospective Payment System (OPPS)
Common Rule
Medicare for All
National Trauma Systems Legislation
Drug Pricing
Patient-Centered Outcomes Research Institute (PCORI)
Measuring Surgical Quality
Medicare Physician Reimbursement
Cancer Research and Funding
Trauma Research and Funding
Opioids/Pain Management Legislation
ACS THRIVE (Transforming Health care Resources to Increase Value and Efficiency)
Reauthorization of Patient-Centered Outcomes Research Institute (PCORI)
2020 CMS Proposed Fee Schedule
Rare earth magnet legislation
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Medicare Payment Advisory Commission (MedPAC), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christian |
Shalgian |
|
|
|
Patrick |
Bailey |
MDFACS |
|
|
Matthew |
Coffron |
|
|
|
Carrie |
Zlatos |
|
|
|
Kristin |
McDonald |
|
|
|
Katie |
Oehmen |
|
|
|
Hannah |
Chargin |
|
|
|
Amelia |
Suermann |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
PL 109-417 - Pandemic and All-Hazards Preparedness Act (PAHPA)
PL 116-127/H.R. 6201 - Families First Coronavirus Response Act
H.R. 6365/S. 3559 - The Immediate Relief for Rural Facilities and Providers Act
H.R. 748/S. 3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act
S. 1895 - Lower Health Care Costs Act
H.R. 5800 - Ban Surprise Billing Act
H.R. 5826 - Consumer Protections Against Surprise Medical Bills Act
H.R. 3630 - No Surprises Act
H. R. 8 - Bipartisan Background Checks Act of 2019
H. R. 1418 - Competitive Health Insurance Reform Act of 2019
S. 668/H.R. 1570 - Removing Barriers to Colorectal Cancer Screening Act of 2019
S. 966 - Medicare Care Coordination Improvement Act of 2019
S. 2372 - VA MISSION Act of 2018
S. 741/H. R. 1730 - Cancer Drug Parity Act of 2019
H. R. 1379 - Ensuring Lasting Smiles Act
H. R. 207 - Stop the Violence Act of 2019
H. R. 1841 - Ensuring Access to General Surgery Act of 2019 (and Senate version reintroduction)
H. R. 1041 - Critical Access Hospital Relief Act of 2019
H.R. 3656/S. 1350 - ACCESS Act of 2019
H.R. 861 End Surprise Billing Act
H.R. 3630 No Surprises Act
H.R. 3502 Protecting People from Surprise Medical Bills Act
H.R. 2550 - Prevent BLEEDing Act of 2019
H. R. 2143 - Promoting Integrity in Medicare Act of 2019
H. R. 3107 - Improving Seniors' Timely Access to Care Act of 2019
H. R. 1332 - Fair Care Act of 2019
H.R. 2464 - End the Cycle of Violence Act of 2019
S. 1895 Lower Health Care Costs Act
S. 967 Reducing Costs for Out of Network Services Act
S. 1266 Protecting Patients from Surprise Medical Bills Act
S. 1531 Stopping the Outrageous Practice of Surprise Bills Act
S. 1607 Medical Billing Fairness Act
H. R. 1763/S. 348 - Resident's Physician Shortage Reduction Act
S. 1350 - Good Samaritan Health Professionals Act
H. R. 2689/S. 1438 - Breast Cancer Research Stamp reauthorization
H.R. 4350/S. 3085 - Ambulatory Surgical Center Quality and Access Act of 2019
Cures 2.0
E/M Global Code Issues
Unique Patient Identifier
Lower Health Care Costs Act Compromise
Bleeding Control for the Injured (Stop The Bleed campaign)
Qualified clinical data registry (QCDR)
Firearms Safety and Research
MACRA Implementation
Merit-based Incentive Payment Systems (MIPS)
Alternative Payment Models (APM)
Outpatient Prospective Payment System (OPPS)
Common Rule
Medicare for All
National Trauma Systems Legislation
Drug Pricing
Patient-Centered Outcomes Research Institute (PCORI)
Measuring Surgical Quality
Medicare Physician Reimbursement
Cancer Research and Funding
Trauma Research and Funding
Opioids/Pain Management Legislation
ACS THRIVE (Transforming Health care Resources to Increase Value and Efficiency)
Reauthorization of Patient-Centered Outcomes Research Institute (PCORI)
2020 CMS Proposed Fee Schedule
Rare earth magnet legislation
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Medicare Payment Advisory Commission (MedPAC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christian |
Shalgian |
|
|
|
Patrick |
Bailey |
MDFACS |
|
|
Matthew |
Coffron |
|
|
|
Carrie |
Zlatos |
|
|
|
Kristin |
McDonald |
|
|
|
Katie |
Oehmen |
|
|
|
Hannah |
Chargin |
|
|
|
Amelia |
Suermann |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Cancer Research and Funding
Opioid Legislation
Firearms CDC Research Funding
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christian |
Shalgian |
|
|
|
Patrick |
Bailey |
MDFACS |
|
|
Matthew |
Coffron |
|
|
|
Carrie |
Zlatos |
|
|
|
Kristin |
McDonald |
|
|
|
Katie |
Oehmen |
|
|
|
Hannah |
Chargin |
|
|
|
Amelia |
Suermann |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
S. 2372 - VA MISSION Act of 2018
H.R. 880/S. 1022 - Mission Zero Act
National Trauma System (Military-Civilian Trauma Care)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christian |
Shalgian |
|
|
|
Patrick |
Bailey |
MDFACS |
|
|
Matthew |
Coffron |
|
|
|
Carrie |
Zlatos |
|
|
|
Kristin |
McDonald |
|
|
|
Katie |
Oehmen |
|
|
|
Hannah |
Chargin |
|
|
|
Amelia |
Suermann |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |